Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Severity and Disease Progression in Influenza-like Illness

NCT04664075 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04664075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04664075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Severity and Disease Progression in Influenza-like Illness
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Terminated
Start date
January 25, 2021
Completion date
April 30, 2022
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, infection viral, infection, bacterial, influenza, respiratory tract infections, respiratory viral infection, rna virus infections, sars (severe acute respiratory syndrome)